Loading...
Loading...
Browse all stories on DeepNewz
VisitWill a clinical trial targeting therapies for RNU4-2 related NDD start by end of 2024?
Yes • 50%
No • 50%
ClinicalTrials.gov or relevant clinical trial registry
Nature Study Links RNU4-2 Variants to 0.4% of Neurodevelopmental Disorders
Jul 12, 2024, 01:08 AM
A groundbreaking study published in Nature has identified de novo variants in the RNU4-2 snRNA as a frequent cause of neurodevelopmental disorders (NDD). The research highlights that mutations in the RNU4-2 gene, a non-coding gene encoding a small nuclear RNA (snRNA), are linked to a significant number of NDD cases, explaining up to 0.4% of these disorders. Notably, the de novo variants, which involve a stretch of 18 bp, were all found on the maternal allele. This discovery marks a landmark moment in the history of NDD genetics, with hundreds of individuals already diagnosed with severe developmental delays due to these mutations.
View original story
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Less than 500 • 25%
More than 1500 • 25%
1001-1500 • 25%
500-1000 • 25%
RNU4-3 • 25%
Other • 25%
RNU4-1 • 25%
RNU4-4 • 25%